"What is driving you to bring up the question about the brain capacity all the time?"
The use of many useless and stupid words does not change that into smartness. That's not a matter of language but of brain. People know truth is short. People also know master Savage's barking dogs.
I liked that one.
So we are both in it for a better deal than 15% and 10 million as upfront? It's just so hard waiting?
The IDIS agreement must be painful for you.
Or - Do you acctually admit that if a sellforce of Epicept sells 3000 Ceplene treatments in Europe the BP could never - never - sell for a higher net revenue than Epicept taking the gross them selfs, given the limitation of the new patient group each year (16 000)? Using your figures (15%) as assumtions.
How will your next post about the dilution gost look like?
I'll give you a clue: You have to show that the IDIS agreement given a life safing drug with exclusive rights on the market will not reach the market. My figures of at least 100 new treatments each month is all wrong.
I hope this discussion might be seen as a metaphor for the negotiations and where the energy is right now.
In broken English,
you're not upset because you sold everything at .82 are you :)
I could see things going either way! I wish they had some news, because the stock is primed....I don't think profit takers will take it to .66 though (acutally I see long term support at .68), there was too much volume in the .79+ range...a lot of new owners.